A

Aida Pharmaceuticals Inc

AIDA, USA

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
AIDA
stock
AIDA

Bihar’s NBPDCL bags Gold Award from AIDA MillenniumPost

Read more →
AIDA
stock
AIDA

Writer Aida Rivera Ford, pride of Davao City, dies short of 100th birthday MEXC

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2008-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.00

Low 1

High 3

Return on Equity (ROE)

-

Very High

25.01 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

3.10 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-3.40 %

Low 5%

High 15%

Debt to Equity

-

Very Low

6.19

Low 1

High 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Aida Pharmaceuticals Inc

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

EPS Estimate

Latest Release

Date

2008-09-30

EPS Actual

0.0848

EPS Estimate

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2008-09-30)

Deep Value
Strong Deep Value(8)
Defensive
Moderately Defensive(5.5)
Dividend
Decent Dividend Payer(3.5)
Economic Moat
Wide Moat Company(6.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(3)
Momentum
Strong Momentum(7)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Moderate Quality(6)
Value
Undervalued(8.5)

Income Statement

(Last Updated 2008-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2008-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2008-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.